# FDA 483 - OMRIX Biopharmaceuticals LTD - February 16, 2020

Source: https://www.globalkeysolutions.net/records/483/omrix-biopharmaceuticals-ltd/95c3cca2-bbf4-4923-8eaf-627f601c7a13

> FDA 483 for OMRIX Biopharmaceuticals LTD on February 16, 2020. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: OMRIX Biopharmaceuticals LTD
- Inspection Date: 2020-02-16
- Product Type: biologics
- Office Name: International Compliance Team

## Related Documents

- [483 - 2020-02-16](https://www.globalkeysolutions.net/records/483/omrix-biopharmaceuticals-ltd/cecc006d-0b3f-49b5-825d-d455a6ed2497)

## Related Officers

- [Steven F. Bowen, Ph.D., CSO](https://www.globalkeysolutions.net/people/steven-f-bowen-phd-cso/1462411c-dce8-47e5-95cd-0e3e62345a22)
- [CSO](https://www.globalkeysolutions.net/people/mihaly-s-ligmond/2904ef70-a757-49c7-9ac4-a2c07ee36001)
- [Chava Kunchi-Sarfaty, Ph.D., Research Chemist](https://www.globalkeysolutions.net/people/chava-kunchi-sarfaty-phd-research-chemist/45f9f09b-a3a6-43a9-9169-1c96165c782f)

Company: https://www.globalkeysolutions.net/companies/omrix-biopharmaceuticals-ltd/bf1b8f1e-b1c7-47be-bb38-f85e1cff944d

Office: https://www.globalkeysolutions.net/offices/international-compliance-team/f0ce0d89-bf39-46c6-8c42-28138d161321